The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/-pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments

D Serrano, S Torrado… - Current Drug …, 2012 - ingentaconnect.com
Proton pump inhibitors (PPIs) are the most potent acid suppressants available. PPIs
undergo hepatic metabolism via the CYP2C system for the isoforms CYP2C19 and CYP3A4 …
被引用次数：46 相关文章

The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/-pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments

D Serrano, S Torrado… - Current drug …, 2012 - pubmed.ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) are the most potent acid suppressants available. PPIs
undergo hepatic metabolism via the CYP2C system for the isoforms CYP2C19 and CYP3A4 …

[引用][C] The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/-Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treat …

D Serrano, S Torrado… - The Influence of …, 2012 - produccioncientifica.ucm.es

The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/-pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments.

D Serrano, S Torrado, S Torrado-Santiago… - Current Drug …, 2012 - europepmc.org
Proton pump inhibitors (PPIs) are the most potent acid suppressants available. PPIs
undergo hepatic metabolism via the CYP2C system for the isoforms CYP2C19 and CYP3A4 …